Skip to main navigation
Starling Oncology Logo
  • IR Home
  • News & Events
    News Releases Events & Presentations
  • Stock Information
    Stock Quote & Chart
  • Governance
    Governance Documents Board of Directors Management Team Committee Composition
  • Financials
    SEC Filings
  • Resources
    FAQs Email Alerts Contact IR

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
November 12, 2026
Document Date
November 12, 2026
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Starling Oncology
Issuer
STARLING ONCOLOGY, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Investor FAQs
  • © 2026 Starling Oncology. All rights reserved.